Clopidogrel vs. Aspirin for Heart Protection in Blood Infection Patients
Treatments studied
Part of Blood & lymphatic, Heart & circulation, Infections clinical trials.
This trial tests whether switching from aspirin to clopidogrel better protects your heart and blood vessels during recovery from a serious staph infection in the blood. You may be eligible if you currently take aspirin for heart or stroke prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently taking aspirin to prevent heart attack, stroke, or other blood vessel problems
- You do not have active bleeding right now
- You are not planning major heart, brain, or spine surgery in the next 3 days
- You are not pregnant
- You have not taken clopidogrel, prasugrel, or ticagrelor in the past month
- You are not allergic to clopidogrel and are not taking a blood thinner called an oral Xa inhibitor
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of blood thinners (dabigatran vs. a common Xa inhibitor like apixaban) in people with a staph infection in their blood. The goal is to see which is safer and works better.
This trial tests whether adding clopidogrel, a blood-thinning medicine usually used for heart conditions, can improve outcomes for patients with a serious staph infection in the blood, called Staphylococcus aureus bacteremia. Clopidogrel may help reduce the damage caused by the bacteria.
This trial tests switching from a standard blood thinner (clopidogrel) to a lower dose of a stronger one (prasugrel) in people who have had a stent placed and are at high risk for both bleeding and heart problems. The goal is to see if the switch better prevents clots while keeping bleeding risks low.
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
This study compares two blood-thinning medications—aspirin and clopidogrel—in people with chronic coronary artery disease (narrowed heart arteries). Researchers want to learn which medication works better at preventing heart problems over 5 years.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
Hear when a new Staphylococcus Aureus Endocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.